Select your products and services :
Select your country :
Americas
Europe
Asia and South Pacific
Middle East and Africa

Update your choices | BU : Life Science | Country : USA
> >

Oligonucleotides

Since 1987, Eurogentec has provided oligonucleotides of the highest quality whatever the application, even the most demanding ones (NMR, X-Ray Crystallography, in vivo use...). Our Oligonucleotide synthesis Service offers a large variety of synthesis scales, more than 100 modifications and an extensive range of purifications, formats and packagings. During the last 20 years, we have synthesised highly modified oligonucleotides, sophisticated chimeras, siRNA coupled to various peptides, oligonucleotides containing multiple G-stretches, aptamers, large scale oligonucleotides...

Today, more than 35 000 customers recognise Eurogentec as a true partner to their experiments.

Will you become the next one?

Products

  • All types of oligonucleotides, from 2 to 220 bases
  • All chemistries: DNA, RNA, LNA®, 2’O-Me, PNA
  • More than 100 modifications
  • All synthesis scales, from μg to grams
  • Large range of Real-Time qPCR probes
  • RNAi Oligonucleotides including siRNA duplexes and miRNA inhibitors

Trusted quality

  • Fully automated synthesis
  • Optimised chemistry
  • Stringent Quality Controls
  • ISO 9001:2000 Certified Quality System
  • ISO 13485:2003 Certified for IVD oligonucleotides
  • Fast turnaround times through
  • User-friendly web ordering interface
  • Technical and scientific assistance assumed by experienced scientists 
  • High-capacity and flexibility 
  • Parallel synthesis up to 10 000 oligos per day 
  • Easily scalable up to 100 grams, under cGMP quality

True partnership

  • Fast turnaround times, including Same Day Shipping
  • Technical and scientific support, staffed by qualified and experienced scientists, in Molecular Biology and Chemistry
  • Manufacturing facilities in 4 countries (Belgium, USA, Japan and Singapore)

We use cookies to ensure the best experience on our website. By continuing to use this website, you consent to our cookie policy.